Helpline
Call 1.855.378.4373 to schedule a call time with a specialist or visit scheduler.drugfree.org
Helpline
Helpline
Call 1.855.378.4373 to schedule a call time with a specialist

The Latest News from Our Field

We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.

Almost 60% of teenage girls felt persistently sad or hopeless in 2021, according to a new government survey.
A new study suggests taking the medication naltrexone before consuming alcohol may help people reduce binge drinking, The New York Times reports.
The cost of buprenorphine treatment for opioid use disorder decreased from 2015 to 2020, according to a new study. But costs varied widely depending on a patient’s insurance, Axios reports.
Find more of our must-reads in policy news, including the removal of the buprenorphine waiver requirement.
View our curated digest of the latest research news, including the association between opioid tapering and subsequent health care use, medication adherence and chronic condition control.
The federal government is taking a number of steps to crack down on fentanyl smuggling along the southern border, President Biden said Tuesday night in his State of the Union address.
As more data emerges on marijuana’s health effects, policymakers are seeking to increase regulation and oversight of the loosely regulated marijuana marketplace, Politico reports.
Nearly two-thirds of adults support prohibiting menthol cigarette sales, while more than half support banning all tobacco product sales, according to a new survey from the Centers for Disease Control and Prevention.
Find more of our must-reads in policy news, including President Biden highlighting mental health and addiction in his State of the Union.
View our curated digest of the latest research news, including the association between state cannabis legalization and psychosis-related health care utilization.
A new study finds substance use among teens decreased between 2019 and 2020, including marijuana, tobacco and misused prescription drugs, CNN reports.
Addiction treatment centers have become increasingly attractive to private equity firms looking for big returns, according to CBS News.
The U.S. Food and Drug Administration announced it will not regulate CBD supplements because of a lack of evidence on their safety, HealthDay reports.
Find more of our must-reads in policy news, including the first waiver approved to allow Medicaid services prior to release from incarceration.
View our curated digest of the latest research news, including an examination of awareness of, susceptibility to and use of oral nicotine pouches in young adults as well as comparative risk perceptions with smokeless tobacco.
A new study suggests many teens who could benefit from medication for opioid use disorder are not receiving it, HealthDay reports.
Changes in addiction medication prescribing rules implemented during the pandemic did not increase the proportion of opioid overdose deaths involving buprenorphine, according to a new study.
Doctors are prescribing opioids to emergency department patients at discharge less often, a new study finds.
Find more of our must-reads in policy news, including advocates expressing concern about flavored marijuana products targeting kids.
View our curated digest of the latest research news, including the potential for individual risk factors to predict substance use treatment course patterns.
Allowing specially trained pharmacists to prescribe medication to treat opioid use disorder can greatly increase rates of continued care, a new study finds.
As the number of patients with opioid use disorder who develop the life-threatening heart condition endocarditis increases, hospitals are struggling to provide adequate treatment, STAT reports.
The number of people age 65 and up involved in marijuana-related emergency room visits in California jumped from 2005 to 2019, according to new research.
Find more of our must-reads in policy news, including the removal of the buprenorphine waiver requirement by SAMHSA and the DEA.
View our curated digest of the latest research news, including the association between prenatal cannabis use disorder and infant hospitalization or death in the first year of life.
1 10 11 12 13 14 359